Nanoviricides (FRA:NV3P) Total Liabilities: €0.92 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:NV3P Nanoviricides Inc FRA:NV3P
39 GF Score
Price €1.42
! 1 Warning Sign
View Full Analysis

What is Nanoviricides Total Liabilities?

Nanoviricides FRA:NV3P +7.30% 39 Total Liabilities is €0.92 Mil as of Mar. 2026. GuruFocus rates FRA:NV3P with a GF Score™ of 39/100. The stock has 1 warning sign investors should review.

Nanoviricides's Total Liabilities for the quarter that ended in Mar. 2026 was €0.92 Mil.

Nanoviricides's quarterly Total Liabilities increased from Sep. 2025 (€1.01 Mil) to Dec. 2025 (€1.02 Mil) but then declined from Dec. 2025 (€1.02 Mil) to Mar. 2026 (€0.92 Mil).

Nanoviricides's annual Total Liabilities declined from Jun. 2023 (€1.88 Mil) to Jun. 2024 (€1.26 Mil) and declined from Jun. 2024 (€1.26 Mil) to Jun. 2025 (€1.13 Mil).

Nanoviricides Total Liabilities Historical Data

* Premium members only.

The historical data trend for Nanoviricides's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanoviricides Total Liabilities Chart

Nanoviricides Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.29 0.39 1.88 1.26 1.13

Nanoviricides Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.11 1.13 1.01 1.02 0.92
FRA:NV3P
39GF Score
Nanoviricides Inc FRA:NV3P
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nanoviricides Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Nanoviricides's Total Liabilities for the fiscal year that ended in Jun. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.133+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1.13

Total Liabilities=Total Assets (A: Jun. 2025 )-Total Equity (A: Jun. 2025 )
=7.65-6.518
=1.13

Nanoviricides's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.921+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.92

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=8.839-7.918
=0.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €0.92 Mil mean?
Nanoviricides (FRA:NV3P) has a Total Liabilities of €0.92 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Nanoviricides and its competitors.
Is Nanoviricides' Total Liabilities too high?
Nanoviricides' current Total Liabilities is €0.92 Mil. Overall, Nanoviricides has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Nanoviricides' Total Liabilities compare to LSTA and SGMO?
Nanoviricides' Total Liabilities of €0.92 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Nanoviricides and its competitors. Nanoviricides's current Total Liabilities is €0.92 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanoviricides stock overvalued right now?
Nanoviricides (FRA:NV3P) has a current Total Liabilities of €0.92 Mil. The current Total Liabilities is €0.92 Mil. Nanoviricides' overall GF Score™ is 39/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Nanoviricides (FRA:NV3P), the current Total Liabilities is €0.92 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nanoviricides Business Description

Other Exchanges NNVC:USA
Address 1 Controls Drive, Shelton, CT, USA, 06484
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
39GF Score

Get the complete analysis for FRA:NV3P

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.42
Price